A Case Study of A 1-Year-Old Child Diagnosed With Bronchial Asthma in Acute Exacerbation
A 1-year-old male infant was admitted to the hospital with cough, colds, and asthma exacerbation. Upon examination, he had rapid breathing, wheezing, and chest retractions. Over a few days of treatment including antibiotics, nebulizers, and IV fluids, his symptoms improved with stable vital signs and decreased wheezing. He was discharged with medications and instructions to follow up in one week.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0 ratings0% found this document useful (0 votes)
457 views36 pages
A Case Study of A 1-Year-Old Child Diagnosed With Bronchial Asthma in Acute Exacerbation
A 1-year-old male infant was admitted to the hospital with cough, colds, and asthma exacerbation. Upon examination, he had rapid breathing, wheezing, and chest retractions. Over a few days of treatment including antibiotics, nebulizers, and IV fluids, his symptoms improved with stable vital signs and decreased wheezing. He was discharged with medications and instructions to follow up in one week.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 36
2 NF PRESENTS
A Case Study of a 1-year-old Child Diagnosed with
Bronchial Asthma in Acute Exacerbation Assessment Patient X is a 1-year-and-3-month-old male infant from Indahag, Cagayan de Oro City. On December 1, 2020, at 3:30 PM, Patient X was admitted to Maria Reyna - Xavier University Hospital with a chief complaint of cough and colds and an admitting diagnosis of pediatric community-acquired pneumonia with asthma. Upon physical examination, the patient was conscious and was not lethargic nor drowsy. His vital signs upon admission were at temperature of 36.6 degrees Celsius, respiratory rate of 44 breaths per minute, heart rate of 188 beats per minute, and oxygen saturation of 97%. Rales were heard in both lungs upon auscultation and intercostal retraction was evident. Upon assessment, he weighed 11.5 kilograms and was noted to be formula-fed. He was delivered via normal spontaneous delivery (NSD) without any complications at JRB Hospital, Cagayan de Oro City. Immunizations received by Patient X include BCG, DPT 3, OPV 3, and HIB 3. The mother is the primary caregiver. At 1 year old, the patient is able to walk alone and able to say “mama” and “papa.” Patient X has a family history of bronchial asthma from the maternal side. In the past two weeks, Patient X presented with the following symptoms: vomiting, dry cough, runny nose, and shortness of breath. His RT-PCR test result came in negative for COVID-19 Infection. One day prior to admission, Patient X had a sudden onset of a non-productive cough, with clear nasal discharge; but without fever, LBM, and vomiting. He was given salbutamol syrup (self-medicated) 0.5mL x 3 doses. Morning prior to admission, Patient X had a recurrence of symptoms associated with fast breathing, with decreased appetite and decreased milk formula intake (6oz from normal intake of 180z), and post-tussive vomiting. On the day of admission, he was seen by the attending physician, which prompted admission. On the second day of admission, December 2, 2020, upon assessment at 6:30 AM, Patient X was afebrile, had decreased tachypnea with a respiratory rate of 50-52 breaths per minute, and decreased intercostal retractions. Rales were still heard upon auscultation. Heart rate was 150 beats per minute and oxygen saturation was at 97%. Patient X was reported to be eating better. Diet for age was allowed but with strict aspiration precaution and continuation of medications was ordered. At 3:00 PM, IVF rate was ordered to be decreased to a rate of 50 cc/hr with an additional order of IVF to follow D5IMB (balanced multiple maintenance solution) at 50 cc/hr in cycles until further notice. At 7:40 PM, Patient X remained afebrile with a respiratory rate of 50 beats per minute. Heart rate was 120 beats per minute and oxygen saturation was at 98%. Bilateral rales were still heard upon auscultation and chest retraction was still present with an occasional wheeze. Chest tapping after every nebulization was then instructed along with the continuation of his treatment with Ceftriaxone D1. On December 3, 2020, Patient X was placed safely at the center of the bed, with side rails raised. The mother was instructed not to leave the patient unattended due to medications given, kept watch for any unusualities. At 9:40 AM, assessment of Patient X revealed that he was afebrile and had a good appetite. His vital signs that time were: heart rate - 110, respiratory rate - 20, SPO2 - 98% - room air (RA), tolerated well. Bilateral rales were still positive upon auscultation and audible wheeze was still present, however, there were no observable retractions upon examination. He continued his course of antibiotic therapy (Ceftraixone D1+1). Patient X’s oxygen was ordered to be discontinued with the order to refer if with desaturation (<95% sat). His IV fluid was ordered to be decreased to a rate of 45cc/hr with IV fluid to follow (D5IMB at 45 cc/hr). Nebulization interval was decreased to q4. At 4:00 PM, Patient X’s follow-up assessment revealed that the audible wheeze was still present, however, no retractions were observed. His vital signs were: blood pressure - 90/60 mm/Hg, heart rate - 114 bpm, respiratory rate - 30 cpm, and SPO2 - 99% at room air. On the last day of admission, December 4, 2020, at 9AM, no wheezing was noted upon auscultation and retractions were not evident. His vital signs were as follows: blood pressure - 90/60, heart rate - 114 BPM, respiratory rate - 28-38 CPM, and oxygen saturation - 98%. Patient was advised to do chest tapping every after nebulization and was encouraged to increase oral fluid intake (OFI). At 11 AM, Patient X was afebrile, no wheezing and retractions were noted, and oxygen saturation was at 97% at room air (RA). Patient was ordered to consume the remaining ceftriaxone 600 mg and was ordered to shift to co-amoxiclav (Natravox) 250 mg/62.5 mg every 5 mL, 2.5 mL TID. The physician instructed not to reinsert IV line once dislodged. IVF rate was decreased to 30cc/hour and salbutamol + ipratropium was discontinued. Salbutamol was increased to 1 nebule q4h and hydrocortisone was continued. At 11:30 AM, Patient X was discharged with the final diagnosis of bronchial asthma in acute exacerbation. The following were the take-home medications: salbutamol 1 nebule q6h for 5 days, co-amoxiclav 250 mg/62.5 mg, prednisone 20mg/5mL, and phenylpropanolamine HCl + Brompheniramine maleate (Nasatap) drops 1 mL OD. Patient X was instructed to have a follow-up check-up on December 14, 2020 in Maria Reyna Xavier University Hospital clinic at 12 NN. Pathophysiology Thank you!